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We reported the effects of quercetin on metabolic and hormonal proﬁle as well as serum antioxidant
activities in a model of MSG (monosodium glutamate)-induced obesity. Rats were divided into 4 groups:
MSG group, submitted to neonatal treatment with high doses of MSG, administrated subcutaneously dur-
ing 10 days, from 2 day-old; control groups, which received the same volume of saline. After completing
30 day-old, these groups were subdivided into 4 groups: control and MSG groups treated and non-treated
with quercetin at doses of 75 mg/kg body weight (i.p.) over 42 days. BW gain and food consumption were
higher in MSG treated rats and quercetin signiﬁcantly reduced BW by 25%. While MSG increased triacyl-
glycerol, total cholesterol and fractions, and reduced HDL concentrations, administration of quercetin
normalized HDL-cholesterol and reduced others lipids. Insulin, leptin, glucose and creatinine levels were
raised in MSG-treated rats and reduced after quercetin treatment. Alanine transaminase, aspartate trans-
aminase, lactate dehydrogenase and alkaline phosphatase activities were lower after MSG-quercetin
combination compared to rats given only MSG. MSG-quercetin combination augmented total protein
and urea levels as well as glutathione peroxidase and superoxide dismutase activities in contrast to
MSG-treated animals. Quercetin normalized serum lipid and glucose proﬁle and minimized the MSG-
related toxic effects, which was associated to its antioxidant properties.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Eating behavior plays a pivotal role in metabolic and diet-re-
lated disorders (Naim et al., 1991). Some mechanisms for food
cravings may beneﬁt mammals from nutrient deﬁciency, other-
wise overfeeding of palatable food may cause an imbalanced intake
of nutrients (Kaur and Kapoor, 2001). Monosodium glutamate
(MSG) is one of the most abundant naturally occurring non-essen-
tial amino acids and MSG-treatment is able to produce metabolicS, reactive oxygen species;
roxidase; BW, body weight;
l; TC, total cholesterol; HDL,
-density lipoprotein choles-
, gluthatione tripeptide. NBT,
MS, phenazine methosulfate;
ase; LDH, lactate dehydroge-
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lsevier OA license.changes, which can further result in severe bodily disturbances
(Diniz et al., 2005).
The hypothalamus is associated with the control of food intake,
energy balance and the autonomic nervous system. Among major
causes of neuroendocrine obesity is the hypothalamic lesion-in-
duced obesity (Macho et al., 2000), which can be experimentally
induced after s.c. injections of MSG (Nakayama et al., 2003) or
via MSG oral administration (Xu et al., 2007) to suckling rodent
pups. These animal models for studying obesity often present fast-
ing hyperinsulinemia (Maletínská et al., 2006), hyperleptinemia
(Hollopeter et al., 1998), adiposity and increase of plasma fatty
acids and triacylglycerols (Dawson et al., 1997). In addition, post-
natal administration of MSG in rats seems to be linked to insulin
resistance, body weight gain, hyperleptinemia and glucose levels
(Iwase et al., 1998; Suga et al., 1999), but the exact mechanisms
for these alterations are not yet clearly deﬁned.
Although some variables, such as age, via of administration,
dose and period of treatment must be taken account, it is clear that
MSG is able to cause metabolic alterations. In this context some
studies have shown that MSG induces oxidative stress and
hepatotoxicity in rats (Onyema et al., 2006) as well as impaired
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mice (Andreazzi et al., 2009). Recent ﬁndings proposed that MSG
produces altered lipid proﬁle with elevation in reactive oxygen
species (ROS) formation and reduction of antioxidant activities
(Park et al., 2010).
Quercetin (3,30,40,5,7-pentahydroxyﬂavone), a polyphenolic ﬂa-
vonoid compound occurring mainly in glycosidic forms (Wach
et al., 2007), is a potent antioxidant found in vegetables and fruits
capable of inducing hepatoprotection and also improving dyslipi-
demia (Amália et al., 2007). Also, it contains some phenolic hydro-
xyl groups that have strong antioxidant activity, functioning as a
ROS scavenger itself (Boots et al., 2007). Furthermore, growing evi-
dences has pointed to quercetin as a promoter of enhanced super-
oxide dismutase (SOD) and glutathione peroxidase (GSH-Px)
activities (Amália et al., 2007). To date, no reports have focused e
relationship between MSG-toxicity effects and the role of quercetin
on dyslipidemia, energy balance, glucose intolerance/insulin resis-
tance and liver metabolism.
Therefore, the present study was carried out to investigate
whether quercetin is able to improve nutritional parameters, lipid
and hormonal proﬁle, liver and glucose metabolism and serum
antioxidant activities of postnatally MSG-treated rats.
2. Material and methods
2.1. Animals and experimental design
Sixty-four male Wistar rats were obtained from the Department of Biochemis-
try, Bioscience Institute/Campus of Botucatu, UNESP – Univ Estadual Paulista. Ani-
mals were housed in polypropylene cages with laboratory-grade pine shavings as
bedding and maintained under standard conditions (12 h light/12 h dark cycle;
23 ± 1 C room temperature). Food standard Purina (3074 SIF, Purina Ltd., Campi-
nas, São Paulo, Brazil) and ﬁltered water were provided ad libitum. All animals were
divided into four groups (n = 16/group). Control group (CT): fed standard diet and
receiving saline as vehicle; MSG group (MSG): given only MSG (4 mg/g body
weight) from 2 to 12-day old; quercetin-treated group (CT + QC): receiving stan-
dard diet and quercetin at doses of 75 mg/kg body weight (i.p.), started after
30 day-old, over 42 days; MSG-Quercetin group (MSG + QC): receiving MSG, from
2 to 12-day old, and quercetin as treatment, started after 30-day old, over 42 days.
MSG was subcutaneously administered at the dose of 4 mg/g body weight (BW) on
postnatal days 2–12 (Ebling et al., 1998). At 30 days-old, quercetin at dose of 75 mg/
kg BW (Sigma, St. Louis, MO, USA) was dissolved in propyleneglycol as a vehicle and
injected intraperitoneally once in a week, followed by 7 days of interval over
42 days, totalizing 6 applications. Food (g) and water (mL) consumption were daily
measured and body weights (g) were evaluated each week during all experimental
period. Experimental protocols were accepted by Ethical Committee of the Biosci-
ence Institute /UNESP, Brazil, in accordance to the principles of the Canadian Coun-
cil on Animal Care.
2.2. Biochemical and nutritional determinations
At third week quercetin-treatment were determined fasted glycemic index.
After 42 days of treatment (72 days after birth), rats were fasted overnight (12–
14 h) and then submitted to oral glucose tolerance test (OGTT). Glucose was orally
administered by gavage (3 g/kg) at single dose as 20% aqueous solution, and then
glycemia were quantiﬁed before administration and at 30, 60 and 120 min after
glucose administration. Blood glucose was measured by automatic glucose analyzer
(Boehringer Mannheim, Eli Lilly Ltd., São Paulo, Brazil). After OGTT, all rats were
anesthetized (0.1 ml sodium pentobarbital 3%, i.p.) and euthanized by decapitation.
The blood was placed into centrifuge tubes and allowed to clot to obtain the serum.
Triacylglycerol (TG), total cholesterol (TC) and high-density lipoprotein cholesterol
(HDL) were determined in serum by enzymatic method (test Kit CELM diagnosis,
Modern Laboratory Equipment Company, São Paulo, SP, Brazil). The very-low-den-
sity lipoprotein cholesterol (VLDL) was calculated by Friedewald equation and total
protein was also quantiﬁed (Lowry et al., 1951). Low-density lipoprotein cholesterol
(LDL) was selectively precipitated from 60 ll of serum by adding 1 ml of phospho-
tungstic acid (CELM diagnosis, Modern Laboratory Equipment Company, São Paulo,
SP, Brazil) followed by centrifugation at 1400g for 10 min and ﬁnally read at
625 nm. Fat acids determination was achieved from acid-deproteinized samples
(phosphate buffer – pH 6.7) containing chloroform. The mixture chloroform-trieta-
nolamine was ﬁltered with sodium diethyldithiocarbamate to form a colored prod-
uct. Aliquots of serum was used for insulin and leptin determinations through
enzyme immune assay kit (EIA kit, Cayman Chemical, USA) using an ELISA reader
(Biotech Instruments, INC, USA). GSH-Px (E.C.1.11.1.9.) was assayed using 0.15 M
phosphate buffer pH 7 containing 5 mM EDTA, 0.0084 M NADPH, 4 lg ofGSH-reductase, 1.125 M sodium aside and 0.15 M GSH. GSH-peroxidase unit was
deﬁned as lmol of NADPH oxidized per minute per g protein. SOD (E.C.1.15.1.1.)
activity was determined using superoxide radical (O2 )-mediated-nitro blue tetrazo-
lium (NBT) reduction by an aerobic mixture of NADH and phenazine methosulfate
(PMS). The complete reaction system consisted of 50 mM phosphate buffer pH 7.4,
0.1 mM EDTA, 50 lM NBT, 78 lM NADH and 3.3 lM PMS. One unit of SOD was de-
ﬁned as the amount of protein to decrease the reference rate to 50% of maximum
inhibition (Ewing and Janero, 1995). Plasma aspartate transaminase (AST – EC
2.6.1.1), alanine transaminase (ALT – EC 2.6.1.2), lactate dehydrogenase (LDH –
EC 1.1.1.27), amylase (EC – 3.2.1.1), and alkaline phosphatase (ALKP – EC 3.1.3.1)
activities were determined using kits from Sentinel CH (5-20155; Milan-Italy)
and read at 340 nm. Finally, stored serum samples were analyzed for total protein,
urea and creatinine concentrations based on kits obtained from Sentinel CH (5-
20155; Milan-Italy).
Enzyme activities were performed at 25 C using a micro-plate reader (lQuant-
MQX 200 with Kcjunior software, Bio-Tec Instruments, Winooski, Vermont, USA).
Spectrophotometric determinations were performed in a Pharmacia Biotech spec-
trophotometer with temperature-controlled cuvette chamber (UV/visible Ultrospec
5000 with Swift II applications, Cambridge, England, UK). All chemicals and solvents
were purchased from Sigma (St. Louis, Missouri, USA).
Based on food intake and the amount of calories (Seiva et al., 2011), the follow-
ing parameters were calculated:
Energy intake ¼ mean food consumption dietary metabolizable energy
Voluntary food intake ð%Þ ¼ ðmean food consumption
 100Þ=mean body weight
Feed efficiency ¼ mean body weight gain ðgÞ=total food consumptionðgÞ:2.3. Statistical analysis
The results are presented as means ± standard deviations (SD). Statistical com-
parisons were performed by two-way ANOVA analysis of variance (two factors:
MSG administration and quercetin treatment) complemented by Tukey’s test. Sta-
tistical signiﬁcance was set at p < 0.05. Sigma Plot version 11.0 was used for graphic
design and statistics.
3. Results
3.1. Nutritional parameters
As shown in Table 1, MSG-treated rats had increased BW gain
while quercetin treatment reduced efﬁciently BW by about 23%.
Food consumption, energy intake and glucose levels were signiﬁ-
cantly (p < 0.05) higher in MSG-treated rats and became reduced
after quercetin administration. Fat acid levels tended to be elevated
afterMSG-quercetin combination compared toMSGgroup (Table 1).
3.2. Glucose and lipid metabolism
All experimental groups responded to the OGTT showing in-
creased glucose levels after 30 and 60 min. After 120 min., the gly-
cemic proﬁle of MSG group was not reestablished to basal levels
and was higher than CT group. Quercetin administration in MSG-
treated rats reduced signiﬁcantly glucose levels when compared
to MSG group (Fig. 1).
The levels of TG, TC, VLDL-cholesterol and LDL-cholesterol were
higher (p < 0.05) after MSG administration (Fig. 2). Animals receiv-
ing quercetin had signiﬁcantly reduced TG and VLDL-cholesterol
compared to those MSG-QC group. Comparing MSG and MSG-QC
groups, quercetin normalized HDL-cholesterol levels and de-
pressed TG, TC, VLDL-cholesterol and LDL-cholesterol levels
(Fig. 2).
3.3. Hormone assay
Serum insulin and leptin concentrations were signiﬁcantly
higher (p < 0.05) in MSG group than CT group. However, quercetin
treatment had reduced the insulin and leptin levels after MSG
administration by about 20% and 45%, respectively (Fig. 3A and B).
Table 1
Nutritional parameters.
Parameters Groups
CT MSG CT + QC MSG + QC
BW gain (g) 237.13 ± 23.41 269.97 ± 20.30 141.0 ± 30.52a 207.68 ± 13.83bc
Food consumption (g/day) 25.46 ± 2.8 35.03 ± 4.78a 23.42 ± 2.1 31.48 ± 5.34c
Liquid consumption (ml/day) 32.35 ± 4.75 35.19 ± 3.34 31.24 ± 2.50 32.57 ± 4.20
Energy intake (kcal/day) 74.60 ± 3.45 102.60 ± 5.72a 68.64 ± 2.51 92.24 ± 6.38c
Feed efﬁciency (g/kcal) 297.80 ± 19.41 263.12 ± 23.98 205.41 ± 17.20a 223.45 ± 22.65b
Glycemic index (mg/dl) 54.98 ± 5.55 97.38 ± 5.06a 56.03 ± 3.22 88.84 ± 6.32c
Fatty acid (mEq/l) 0.58 ± 0.12 0.48 ± 0.10 0.57 ± 0.09 0.60 ± 0.06
a,b,cp < 0.05 vs. CT, MSG and CT + QC, respectively. Two-way ANOVA complemented by Tukey’s test.
CT: Control group; MSG: glutamate monosodium-treated group; CT + QC: glutamate non-treated group that received quercetin; MSG + QC: glutamate-treated group that
received quercetin.
Fig. 1. Oral glucose tolerance test (OGTT) of control rats (CT); glutamate monoso-
dium-treated group (MSG); glutamate non-treated group that received quercetin
(CT + QC); glutamate-treated group that received quercetin (MSG + QC). Symbols: 
differs signiﬁcantly from CT; # differs signiﬁcantly from MSG. Numbers: 1differs
signiﬁcantly from basal period; 2differ signiﬁcantly from 30 min; 3differ signiﬁ-
cantly from 60 min. All results were discussed adopting p < 0.05.
Fig. 2. Lipidic proﬁle of control rats (CT); glutamate monosodium-treated group (MSG);
group that received quercetin (MSG + QC). TG: triacylglycerol; TC: total cholesterol; HD
lipoprotein. Letters: adiffers signiﬁcantly from CT; bdiffers signiﬁcantly from MSG; cdiffe
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In addition, MSG group exhibited increased activities of ALT,
AST, LDH, ALKP, amylase and creatinine levels, whereas total pro-
tein, GSH-Px, SOD and urea were reduced compared to untreated
rats (Table 2). Notably, quercetin treatment oppositively decreased
ALT, AST, LDH, ALKP, amylase and creatinine levels and also pro-
moted an augment of GSH-Px and SOD activities (Table 2).4. Discussion
The regulation of energy balance is essential to maintain the
control of metabolism and body composition (Scharrer, 1999).
Importantly, MSG has been widely used to induce obesity through
hypothalamic lesions in neonatal period (Nakayama et al., 2003).
Also, Grassiolli et al. (2007) have evidenced glucose disturbances
only in neonatal MSG-treated animals compared to adult MSG
treatment. One of the main causes of hyperglycemia in these rats
is related to a decreased amount of GLUT 4 protein found in adipo-
cytes (Macho et al., 2000).
We proposed to investigate the consequences of MSG-induced
alterations and the role of quercetin on nutritional and metabolical
parameters. The MSG administration increased food and energy
consumption and glucose levels after 72 days of age. In addition,glutamate non-treated group that received quercetin (CT + QC); glutamate-treated
L: high-density lipoprotein; VLDL: very low-density lipoprotein; LDL: low-density
rs signiﬁcantly from CT + QC. All results were discussed adopting p < 0.05.
Fig. 3. Hormonal status: A – insulin and B – leptin concentration of control rats (CT); glutamate monosodium-treated group (MSG); glutamate non-treated group that
received quercetin (CT + QC); glutamate-treated group that received quercetin (MSG + QC). Letters: adiffers signiﬁcantly from CT; bdiffers signiﬁcantly from MSG; cdiffers
signiﬁcantly from CT + QC. All results were discussed adopting p < 0.05.
Table 2
Enzyme activities and serum metabolites concentration.
Parameters Groups
CT MSG CT + QC MSG + QC
ALT (U/l) 84.93 ± 12.47 142.39 ± 26.80a 56.40 ± 9.62a 95.41 ± 10.50bc
AST (U/l) 117.43 ± 14.04 233.36 ± 16.90a 98.11 ± 7.70a 145.39 ± 18.09bc
LDH (U/l) 219.13 ± 22.47 289.20 ± 23.56a 210.83 ± 13.96 213.18 ± 18.76b
ALKP (U/l) 120.97 ± 3.00 233.46 ± 6.82a 126.07 ± 4.28 167.98 ± 5.37bc
GSH-Px (U/nmol/ml) 36.65 ± 4.17 23.21 ± 3.45a 39.91 ± 4.20a 48.97 ± 3.39bc
SOD (U/mg protein) 26.10 ± 2.46 17.06 ± 2.79a 28.60 ± 2.84 39.31 ± 2.52bc
Amylase (UA/l) 172.76 ± 12.61 263.50 ± 15.25a 172.55 ± 6.29 175.41 ± 8.37b
Total protein (g/dl) 7.45 ± 0.50 5.60 ± 0.55a 7.13 ± 0.61 7.10 ± 0.30b
Urea (mg/dl) 37.41 ± 3.06 23.94 ± 1.96a 33.42 ± 1.95a 35.07 ± 2.93b
Creatinine (mg/dl) 1.47 ± 0.17 2.65 ± 0.27a 1.32 ± 0.13 1.45 ± 0.13b
a,b,cp < 0.05 vs. CT, MSG and CT + QC respectively. Two-way ANOVA complemented by Tukey’s test. CT: Control group; MSG: glutamate monosodium-treated group; CT + QC:
glutamate non-treated group that received quercetin; MSG + QC: glutamate-treated group that received quercetin. ALT: alanine aminotransferase; AST: aspartate amino-
transferase; LDH: lactate dehydrogenase; ALKP: alkaline phosphatase; GSH-Px: glutathione peroxidase; SOD: superoxide dismutase.
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ciency, also having a tendency in reducing food and energy intake
in MSG-treated rats. The term feed efﬁciency refers to the amount
of ingested energy which contributes to body weight gain. Flavo-
noids have been described as modulators of lipid homeostasis in
the adipose tissue and liver, through the inhibition of phosphodies-
terases (Peluso, 2006). One of the mechanisms of polyphenols ac-
tions has been attributed to their antioxidant action resulting in
the inhibition of LDL oxidation, but another role for these com-
pounds includes alteration of hepatic cholesterol absorption, tri-
glyceride assembly and secretion (Rivera et al., 2008). Since these
alterations might be considered as a problem of defective energy
balance regulation (Reeds et al., 1996) and after analyzing dietary
effects on energy balance and food-seeking behavior, the potential
involvement of the hypothalamic centers must be recognized. The
development metabolic impairments has been tightly linked to
hyperphagia (Diniz et al., 2005) as evidenced by BW gain, but it
has also found here to be associated with insulin resistance/glu-
cose tolerance, hyperleptinemia and dyslipidemia. In this study,
rats given MSG probably had the center of appetite regulation
compromised. Leptin, a protein secreted by adipocytes, is essential
to induce satiety after binding to its receptor in the hypothalamic
sites; e.g. arcuate nucleus (Dawson et al., 1997). It is believed that
the effects caused by MSG toxicity-related hyperphagia must be
due to an inefﬁciency of leptin to bind its receptor (Aﬁﬁ and Abbas,
2011), thereby increasing serum leptin levels. In rats, plasma leptin
is highly correlated with the size of fat depots within the body
(Wein et al., 2010). In this context, adipose tissue accumulation
is very probably the cause, and hyperleptinemia, the consequence.
In our study, the concentration of fasted circulating glucose wasincreased followed by MSG treatment. These values possibly indi-
cate impaired tissue insulin sensitivity and/or stimulation of hepa-
tic gluconeogenesis. Although the mechanisms causing metabolic
alterations are still obscure, it has been proposed that metabolic
dysfunction is associated with deterioration of pancreatic b-cells
activity (Prentki and Nolan, 2006). Thus, the enhanced glucose-in-
duced insulin releasing contributes to hyperinsulinemia (Grassiolli
et al., 2007). Curiously, insulin oversecretion and alteration in pan-
creatic autonomic nervous system have been reported in these
MSG-obese rodents (Balbo et al., 2002).
Most studies have investigated the wide range of concentration
by which quercetin (1–80 mg/kg/day) may exert their function.
Our protocol is adapted from that previously described by Mahesh
and Menon (2004) who tested the effects of quercetin at doses of
50 and 80 mg/kg/day. In contrast to other studies, we found that
only doses of 75 mg/kg quercetin, during 42 days, were able to
ameliorate all evaluated parameters in a model of MSG-induced
metabolic alterations, as could be seen by the reductions in TG,
TC, VLDL-cholesterol and LDL-cholesterol levels. These protective
effects can be mainly attributed to the antioxidant properties of
quercetin (Arai et al., 2000), indirectly acting on the cholesterol
levels. Therefore, LDL-chol and VLDL-chol would be protected
against deleterious effects arising from oxidative process and its
recognition by target cells would be determined (Carrero et al.,
1998). Other hypothesis includes the role of quercetin on decreas-
ing HMG-CoA reductase activity, an enzyme required for choles-
terol synthesis, the potential of reducing aterogenic index and
lipoperoxidation (Arai et al., 2000; Lapointe et al., 2006). Further-
more, there is growing evidence that quercetin and its glycoside
acts by altering hepatic cholesterol absorption and triglyceride
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esterases in the adipose tissue and liver (Peluso, 2006; Rivera et al.,
2008). These events could, at least partially, explain the great
improvement in lipid proﬁle.
It seems true that insulin sensitivity is inﬂuenced by the redox
state of the organism, whereby oxidative processes may trigger the
development of insulin resistance (Evans et al., 2002). Emerging
data has proved that ROS react with protein thiol moieties to pro-
duce a variety of sulfur oxidations which attenuates insulin recep-
tor signal and inhibits cellular uptake of TG from blood stream
(Chen et al., 2003). This can explain the increased serum TG levels
in MSG animals. Also in this context, antioxidant activities could
be inversely correlated with insulin and leptin resistance.
Administration of quercetin enhanced SOD and GSH-Px activities
in MSG-treated rats and only doses of 75 mg/kg quercetin were
able to reduce both glucose and insulin levels in these rats. It
has been strongly demonstrated that quercetin acts as a powerful
antioxidant by either scavenging ROS after diffusion into the lipid
bilayer membranes or by promoting antioxidant activities (Vieira
et al., 2011). Our data reinforce the hypothesis that quercetin, by
increasing SOD activity up to 1.5-fold to that of the MSG-treated
group, reduces superoxide anions levels in MSG + QC rats. GSH-
Px activity was signiﬁcantly reduced in MSG group, possibly due
to increased hydrogen peroxide concentration. This enzyme is
responsible to protect cells against hydrogen peroxide produced
by SOD, so that increased O2 formation reduced GSH-Px activity
in substrate-limiting process (Myhrstad et al., 2002). The MSG-
quercetin combination increased GSH-Px activity up to 1.35-fold
compared to animals given only MSG. In this context, we reinforce
that ﬂavonoids such as quercetin are able to alter cell redox state,
increasing the expression of c-glutamylcysteine synthetase, the
rate limiting enzyme in the synthesis of GSH (Myhrstad et al.,
2002; Mokhtar et al., 2010).
In addition to its antioxidant action, quercetin seems to protect
the liver and ameliorate hepatic function (Vieira et al., 2011). It was
observed that MSG-induced metabolic alterations resulted in he-
patic and cardiac damage by increasing ALT, AST, LDH and ALKP
activities, as already mentioned by Farombi and Onyema (2006)
and Yousef et al. (2010). Otherwise, quercetin was effective to re-
duce them to normal levels. Changes in ALT and AST activity are
associated with pathological processes that affect the integrity of
cell causing high membrane permeability. LDH is an important ser-
um biomarker to detect cardiac injury, mainly those related to
myocardial ischemia (Qiao et al., 2011). More directly, MSG is
thought to cause cardiovascular damage, while quercetin
administration (Perez-Vizcaino and Duarte, 2010) has improved
this condition. Interestingly, it is believed that quercetin-induced
hepatoprotective effect might be a direct consequence of the redox
state stabilization by the cells (Yousef et al., 2010). Further, MSG-
treated rats had higher amylase activity and creatinine levels as
well as lower total protein and urea than control. Quercetin was
able to attenuate renal impairment in accordance to Singh et al.
(2004), probably due to production of metalothionein, a small cys-
teine-rich protein, capable of acts as heavy metals scavengers and
as a potent antioxidant (Morales et al., 2006). Also, Morales et al.
(2006) showed that quercetin decreased activity concentration of
excretion of ALKP and c-glutamil-transpeptidase, thus suggesting
a protective effect against renal tubular toxicity. These properties
of quercetin could help us to explain, at least in part, our present
ﬁndings. Nevertheless, promising studies focusing on dynamics
of metabolism and the quercetin-involved action(s) mechanisms
are needed.
In conclusion, quercetin successfully improves nutritional
parameters and ameliorates the metabolic alterations caused by
MSG treatment. Moreover, quercetin normalized glucose levels
and minimized the MSG-related toxic effects on liver and kidneyfunctions. These effects are associated to the powerful antioxidant
properties of quercetin. We encourage a high intake of plant foods,
rich in quercetin, as it produces beneﬁcial effects against metabolic
disorders.Conﬂict of Interest
None declared.
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